Cell Biotech Obtains European Patent for Korean Probiotic 'CBT-BR3'

Cell Biotech Duolac.

[Asia Economy Reporter Lee Gwan-joo] Microbiome specialist company Cell Biotech announced on the 19th that it has newly acquired a European patent for a 'growth-promoting functional food composition' related to the Korean probiotic 'CBT-BR3' (Bifidobacterium breve CBT-BR3).

This patent pertains to the patented strain CBT-BR3 developed by Cell Biotech and the functional food composition containing it. The company explained that the strain and composition help digest 'human milk oligosaccharides (HMO),' an essential nutrient source for infants, synthesize vitamin B complex, and have been proven effective in promoting growth and development, enhancing physical strength, and boosting immunity.

Human milk oligosaccharides are immune components found only in human breast milk, known for their prebiotic effects that support the growth of beneficial intestinal bacteria, prevention of infections caused by various pathogens, and enhancement of brain function, making them essential nutrients for infants. However, it has been pointed out that they cannot be broken down by human digestive enzymes and are excreted through feces. Through this patent, it has been confirmed that the CBT-BR3 strain plays a role in breaking down human milk oligosaccharides, thereby promoting the growth of infants and children who consume HMOs.

Cell Biotech uses this strain in its premium probiotic brand Duolac's main children's products, including ▲Duolac Duo D-Drops (0?12 months) ▲Duolac Organic Baby (1?24 months) ▲Duolac YamYam Plus (24 months to 12 years).

Yoon Jong-hyun, head of Cell Biotech's Cell Engineering Research Center, said, "The acquisition of this patent is significant as it demonstrates our capability to develop high-quality strains applicable to growth and development health functional foods." He added, "Along with previously acquired patents related to irritable bowel syndrome, osteoporosis, and diabetes prevention and treatment, we plan to develop various health functional foods utilizing this newly acquired patent."